First-in-human study of alpibectir (BVL-GSK098), a novel potent anti-TB drug.
Pieren M, Abáigar Gutiérrez-Solana A, Antonijoan Arbós RM, Boyle GW, Davila M, Davy M, Gitzinger M, Husband L, Martínez-Martínez MS, Mazarro DO, Pefani E, Penman SL, Remuiñán MJ, Vlasakakis G, Zeitlinger M, Dale GE.
Pieren M, et al. Among authors: penman sl.
J Antimicrob Chemother. 2024 Apr 24:dkae107. doi: 10.1093/jac/dkae107. Online ahead of print.
J Antimicrob Chemother. 2024.
PMID: 38656557